Pulmicort Aerosol, Powder
Product Images NDC 50090-2239

11 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Pulmicort (NDC 50090-2239). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structural Formula (Image 01)

Structural Formula (Image 01)
Chemical structure diagram showing the molecular structure of budesonide, the active ingredient in PULMICORT FLEXHALER 180 ug/1 Aerosol Powder for inhalation.*
FDA Label Image

Figure 1 (Image 02)

Figure 1 (Image 02)
A line graph comparing the change in FEV1 (L) over 12 weeks among three groups: PULMICORT FLEXHALER 180 mcg (2 inhalations twice daily), PULMICORT TURBUHALER 200 mcg (2 inhalations twice daily), and placebo. The vertical axis shows change in FEV1 (L) from 0.0 to 0.5, and the horizontal axis shows weeks from 0 to 12. All treatments show increasing FEV1 improvement over time, with PULMICORT FLEXHALER and TURBUHALER demonstrating better results than placebo.*
FDA Label Image

Figure 2 (Image 03)

Figure 2 (Image 03)
A line graph presenting the change in percent predicted FEV1 over 12 weeks comparing PULMICORT FLEXHALER 90 mcg (4 inhalations twice daily), PULMICORT TURBUHALER 200 mcg (2 inhalations twice daily), and placebo. The x-axis represents weeks, and the y-axis shows percent change in FEV1 from 0 to 8%. The graph shows that both active treatments improve FEV1 over placebo throughout the study period.*
FDA Label Image

Figure 1 (Image 04)

Figure 1 (Image 04)
An instructional diagram of the PULMICORT FLEXHALER aerosol powder inhaler showing labeled parts including the mouthpiece, dose indicator, brown grip, and a separate cover piece.*
FDA Label Image

Figure 2 (Image 05)

Figure 2 (Image 05)
An instructional line drawing showing a hand holding and preparing to activate a PULMICORT FLEXHALER inhalation device by twisting the base with the other hand, demonstrating the loading or priming step for inhalation use.*
FDA Label Image

Figure 3 (Image 06)

Figure 3 (Image 06)
An instructional illustration showing hands holding a Pulmicort Flexhaler inhaler and twisting its base, demonstrating the preparation step before inhalation.*
FDA Label Image

Figure 4 (Image 07)

Figure 4 (Image 07)
An instructional illustration showing a hand holding the Pulmicort Flexhaler inhaler, demonstrating how to prepare or activate it with a 'Click' step indicated below the image. The diagram emphasizes correct handling of the inhaler device.*
FDA Label Image

Figure 5 (Image 08)

Figure 5 (Image 08)
Instructional illustration showing a person inhaling from a Pulmicort Flexhaler device, demonstrating the correct respiratory inhalation technique for the Budesonide aerosol powder inhaler.*
FDA Label Image

Figure 6 (Image 09)

Figure 6 (Image 09)
An instructional illustration showing parts of an inhaler device with dose indicators labeled 100 and 120, possibly demonstrating usage or dose counting for a respiratory aerosol powder inhaler.*
FDA Label Image

Figure 7 (Image 10)

Figure 7 (Image 10)
An instructional diagram showing a close-up of the dose indicator window on a Pulmicort Flexhaler inhaler. The window displays the number 20, indicating the remaining doses in the inhaler device for delivering budesonide aerosol powder by respiratory inhalation.*
FDA Label Image

Label Image (Lbl500902239)

Label Image (Lbl500902239)
PULMICORT FLEXHALER aerosol powder inhalation label showing Budesonide 180 mcg strength. The label includes storage instructions to keep the product at 68 to 77 degrees Fahrenheit, and indicates the package contains 120 metered doses. It is labeled by A-S Medication Solutions with NDC 50090-2239.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.